纵向活体CT结肠成像监测下结直肠息肉的自然史
该回顾性研究纳入475例无症状成人、639枚小息肉,用CTC随访至少两次,平均随访5.1年。398枚息肉切除后行病理评估,其中41枚(6.4%)为组织学进展期;进展期息肉年体积增长+178%,显著高于非进展期(+33%)及未切除/消退者(-3%),90%的进展期息肉达到体积100 mm³和/或年增长率100%。
要点
- 小息肉中6.4%(41/639)最终病理为进展期,包括2例癌和38例管状绒毛状腺瘤。
- 进展期息肉年体积增长+178%,非进展期+33%,未切除/消退者-3%(P < .001)。
- 90%进展期息肉体积达100 mm³或年增长100%,非进展期仅29%。
核心结论
- 最终病理证实为进展期肿瘤的小结直肠息肉表现出显著更快的生长速度和更大的总体尺寸。
研究设计与样本
- 回顾性研究,475例无症状成人(平均年龄56.9岁±6.7,263例男性),639枚息肉(初始平均直径6.3 mm,体积50.2 mm³),2004年4月1日至2020年8月31日行CTC纵向监测,平均随访5.1年±2.9,所有患者至少接受两次CTC检查。
关键影像表现/征象
- 进展期息肉平均年体积增长+178%(腺癌为+752%/年),非进展期+33%/年,未切除、未回收或消退息肉-3%/年(P < .001)。
- 90%组织学进展期息肉达到体积100 mm³和/或年体积增长率100%,非进展期息肉为29%,未切除或消退息肉为16%(P < .001)。
- 进展期息肉的体积-直径比显著大于非进展期息肉。
- 在三个或以上时间点观察的息肉中,多数进展期息肉表现为初始较慢生长间期,随后为较快生长期。
诊断标准与关键数值
- 组织学进展期定义:腺癌、高级别上皮内瘤变或绒毛状成分;本组41枚(6.4%)进展期息肉包括2例癌和38例管状绒毛状腺瘤。
- 进展期息肉判定参考指标:年体积增长率、总体积达100 mm³和/或年体积增长率100%、体积-直径比。
临床应用与阅片要点
- CTC随访中,小息肉若体积快速增大或达到100 mm³和/或年增长100%,提示进展期组织学风险较高。
- 对三个以上时间点随访的息肉,需注意初始缓慢生长后转为快速生长的模式。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background The natural history of colorectal polyps is not well characterized due to clinical standards of care and other practical constraints limiting in vivo longitudinal surveillance. Established CT colonography (CTC) clinical screening protocols allow surveillance of small (6-9 mm) polyps. Purpose To assess the natural history of colorectal polyps followed with CTC in a clinical screening program, with histopathologic correlation for resected polyps. Materials and Methods In this retrospective study, CTC was used to longitudinally monitor small colorectal polyps in asymptomatic adult patients from April 1, 2004, to August 31, 2020. All patients underwent at least two CTC examinations. Polyp growth patterns across multiple time points were analyzed, with histopathologic context for resected polyps. Regression analysis was performed to evaluate predictors of advanced histopathology. Results In this study of 475 asymptomatic adult patients (mean age, 56.9 years ± 6.7 [SD]; 263 men), 639 unique polyps (mean initial diameter, 6.3 mm; volume, 50.2 mm3) were followed for a mean of 5.1 years ± 2.9. Of these 639 polyps, 398 (62.3%) underwent resection and histopathologic evaluation, and 41 (6.4%) proved to be histopathologically advanced (adenocarcinoma, high-grade dysplasia, or villous content), including two cancers and 38 tubulovillous adenomas. Advanced polyps showed mean volume growth of +178% per year (752% per year for adenocarcinomas) compared with +33% per year for nonadvanced polyps and -3% per year for unresected, unretrieved, or resolved polyps (P < .001). In addition, 90% of histologically advanced polyps achieved a volume of 100 mm3 and/or volume growth rate of 100% per year, compared with 29% of nonadvanced and 16% of unresected or resolved polyps (P < .001). Polyp volume-to-diameter ratio was also significantly greater for advanced polyps. For polyps observed at three or more time points, most advanced polyps demonstrated an initial slower growth interval, followed by a period of more rapid growth. Conclusion Small colorectal polyps ultimately proving to be histopathologically advanced neoplasms demonstrated substantially faster growth and attained greater overall size compared with nonadvanced polyps. Clinical trial registration no. NCT00204867 © RSNA, 2024 Supplemental material is available for this article. See also the editorial by Dachman in this issue.
引用
- Pooler BD, Kim DH, Matkowskyj KA, et al. Natural History of Colorectal Polyps Undergoing Longitudinal in Vivo CT Colonography Surveillance. Radiology. 2024. PMID: 38289210. doi:10.1148/radiol.232078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。